Delivered revenue growth in 2HFY23 across all segments to $131.5m (1HFY23: $52.1m). 2HFY23 gross profit increased
to $66.6m (1HFY23: $16.9m) and positive direct contribution of $0.9m (1HFY23: negative direct contribution of $42.7m)
✓ Generated positive operating free cash flow of $14.1m in 2HFY23
- Forums
- ASX - By Stock
- MYX
- 2HFY23 to $131.5m revenue growth
MYX
mayne pharma group limited
Add to My Watchlist
0.30%
!
$5.06

2HFY23 to $131.5m revenue growth
Featured News
Add to My Watchlist
What is My Watchlist?
A personalised tool to help users track selected stocks. Delivering real-time notifications on price updates, announcements, and performance stats on each to help make informed investment decisions.
|
|||||
Last
$5.06 |
Change
-0.015(0.30%) |
Mkt cap ! $410.2M |
Open | High | Low | Value | Volume |
$5.05 | $5.08 | $5.02 | $385.8K | 76.40K |
Buyers (Bids)
No. | Vol. | Price($) |
---|---|---|
1 | 68 | $5.36 |
Sellers (Offers)
Price($) | Vol. | No. |
---|---|---|
$4.76 | 73 | 2 |
View Market Depth
No. | Vol. | Price($) |
---|---|---|
1 | 68 | 5.360 |
2 | 247 | 5.300 |
1 | 687 | 5.230 |
1 | 746 | 5.150 |
1 | 1996 | 5.050 |
Price($) | Vol. | No. |
---|---|---|
4.760 | 17 | 1 |
4.790 | 10 | 1 |
4.800 | 15 | 1 |
4.910 | 221 | 1 |
4.930 | 160 | 4 |
Last trade - 15.59pm 07/08/2025 (20 minute delay) ? |
Featured News
MYX (ASX) Chart |